Fitzpatrick's Dermatology in General Medicine
Chapter 135. Xanthomatoses and Lipoprotein Disorders
如果要儘快掌握本章重點,不妨看一下筆者仿照Surgical Recall寫的Dermatological Recall。
- 建議可以先遮住右邊,想一下答案大概是什麼。
- (5)表示答案有五項。(訣)表示有筆者自編的口訣。
- 建議可以先遮住右邊,想一下答案大概是什麼。
- (5)表示答案有五項。(訣)表示有筆者自編的口訣。
鄭煜彬
| 
Xanthomatoses and Lipoprotein Disorders: introduction | |
| 
 | 
Chlesterol & triglycerides in foamy macrophages | 
| 
 | 
Skin, tendons, tonsillar(Tangier dz) | 
| 
 | 
 | 
| 
 | 
Eruptive, tubo-eruptive or tuberous, tendinous, or planar. | 
| 
 | 
Foam cells: Mφcontain lipid. 
Eruptive: foam cells+ lymphoid cells, histiocytes, neutrophils, and free lipid in the dermis.  
Tuberous/ Tendonous: foam cells+ cholesterol clefts(doubly refractile) 
Xanthelasmata: superficial location/eyelids(striated muscle, vellus hair, and/or a thinned epidermis). | 
| 
Lipid and Lipoprotein Metabolism  | |
| 
 | 
HMG-CoA reductase | 
| 
 | 
1:4 | 
| 
 | 
Eggs, butter, whole milk, and animal fats as found in meat | 
| 
 | 
Plant sterols (β-sitosterol and campesterol) | 
| 
 | 
Bile acids—cholic acid & chenodeoxycholic acid 
Steroid hormones: estrogen, testosterone, & cortisol | 
| 
 | 
cerebrotendinous xanthomatosis(CTX) | 
| 
 | 
小腸→Chylomicrons→血管→chylomicron remnant→肝→VLDL→血管→VLDL remnant(IDL) →肝→LDL→肝/adipocyte 
Mn: C Cr V Vr L(語法:去過血管變~remnant,去過肝變~LDL) | 
| 
 | 
triglycerides | 
| 
 | 
Chylomicrons & HDL | 
| 
 | 
Cholesterol,β-sitosterol and campesterol | 
| 
 | 
Phytosterolemia(β-sitosterol),會造成tendinous xanthomas. | 
| 
 | 
A, B48, CII, E。CII | 
| 
 | 
B48, E。E | 
| 
 | 
B100, CII, E。CII | 
| 
 | 
B100, E。B100 | 
| 
 | 
B100 | 
| 
 | 
apoA-I & apoA-II | 
| 
 | 
Eruptive(severe hypertriglyceridemia) | 
| 
 | 
tubo-eruptive xanthomas (combined hyperlipidemia) | 
| 
 | 
tubo-eruptive xanthomas | 
| 
 | 
tendinous xanthomas(familial hypercholesterolemia) | 
| 
 | 
tendinous xanthomas | 
| 
 | 
Familial hypercholesterolemia(IIa) 
Familial Lipoprotein (a) Excess(tendinous or tubo-eruptive) 
Familial Combined Hyperlipidemia(tendinous or tubo-eruptive)IIb 
Familial Dyslipidemia(tubo-eruptive)III 
Familial Hypoalphalipoproteinemia(tubo-eruptive)IV 
Tangier Disease(yellow/orange hyperplastic tonsils) | 
| 
 | 大多不會 | 
| 
 | 
Familial Hypercholesterolemia(tendinous)IIa 
Phytosterolemia(tendinous) 
Cerebrotendinous Xanthomatosis(tendinous) 
Dysbetalipoproteinemia(tubo-eruptive)III 
Marked HDL Deficiency(tubo-eruptive) | 
| 
 | 
Subcutaneous nodules in fascia, ligaments, extensor tendons of hands, knees, elbows, and Achilles tendons | 
| 
 | 
Sterols: cholesterol,  | 
| 
 | 
Familial hypercholesterolemia (FH, LDL>300mg/dL), phytosterolemia (plant sterols: β-sitosterol and campesterol), or cerebrotendinous xanthomatosis (cholestanol). | 
| 
 | |
| 
 | 
Homozygous familial hypercholesterolemia, heterozygous familial hypercholesterolemia, or defective apoliprotein-B100 | 
| 
 | 
Tendinous or tuberous xanthomas. | 
| 
 | 
Arcus senilis, tendinous xanthomas, xanthelasma  
LDL↑, normal TG & HDL.  | 
| 
 | 
Tubo-eruptive xanthomatous plaques (over the extremities, buttocks, and hands), Intertriginous xanthomas(極具指標性), CHD/aortic stenosis <20y/o, LDL>600mg/dL(heterozygous>300 mg/dL) | 
| 
 | 
服用Statins+ ezetimibe,使LDL <130 mg/dL 
有必要時LDL apheresis | 
| 
 | 
Elevated LDL cholesterol, plasma β-sitosterol & campesterol | 
| 
 | 
tendinous and tuberous xanthomas and premature CHD | 
| 
 | 
Ezetimibe | 
| 
 | 
Cholestanol | 
| 
 | 
Cerebellar ataxia and dementia, tendinous xanthoma | 
| 
 | 
Defects in the sterol 27-hydoxylase gene | 
| 
 | 
Oral chenodeoxycholate 250 mg TID | 
| 
 | 
Combined hyperlipidemia(Cholesterol+ TG) & marked HDL deficiency, monoclonal gammopathies, multiple myeloma | 
| 
 | 
Cholesterol+TG= intestinal and liver remnant lipoprotein particles (dysbetalipoproteinemia) | 
| 
 | 
Dietary modification, statins, fibrates, and niacin | 
| 
 | 
Chylomicron remnants & VLDL remnants(IDL). | 
| 
 | 
ApoE deficiency,或apoE2/2(正常為3/3),hepatic lipase deficiency | 
| 
 | |
| 
 | 
Adult with xanthoma striatum palmare(characteristic) ,  
Tubo-eruptive xanthomas on their elbows, hands, and even ears 
Premature CHD, gout, and diabetes | 
| 
 | 
↑non HDL cholesterol (total cholesterol—HDL cholesterol>200 mg/dL) and ↑remnant lipoprotein cholesterol (>100 mg/dL) 
HDL正常,LDL降低 | 
| 
 | |
| 
 | 
都正常 | 
| 
 | 
apoA-I  | 
| 
 | 
Corneal opacification, premature CHD in their 30s. tubo-eruptive xanthomas, palmar and planar xanthomas  | 
| 
 | 
HDL cholesterol <10 mg/dL | 
| 
 | 
optimizing all CHD risk factors (LDL <70 mg/dL, TG <150 mg/dL, no smoking, BP <130 mmHg, and HbA1c <7.0%), | 
| 
 | 
monoclonal gammopathies, multiple myeloma, lymphoma and various forms of leukemia | 
| 
 | 
Igs bind lipoprotein,延遲chylomicron remnants or VLDL remnants之清除(兩者會高)。 | 
| 
 | 
Tubo-eruptive, planar, and palmar xanthomas(同combined hyperlipidemia or dysbetalipoproteinemia) | 
| 
 | 
治療underlying disorder, fenofibrate | 
| 
 | 
Prolonged obstruction of the biliary tree (primary biliary cirrhosis and secondary biliary obstruction.) | 
| 
 | 
↑ unesterified cholesterol.  | 
| 
 | 
Plane xanthomas (plaques on hands, feet, and trunk), xanthelasma, and tuberous xanthomas.  
Jaundice, pruritus, and hyperpigmentation of the skin | 
| 
 | 
解決obstruction. liver transplantation for stage 4 disease. | 
| 
 | 
Yellow macules, soft papules, or plaques on the upper eyelids (xanthelasma palpebrarum), the wrists and palms (xanthoma striatum palmare), and in intertriginous area. | 
| 
 | 
Eyelids, elevated LDL cholesterol 或完全健康的人 | 
| 
 | 
Ablative laser therapy(最佳), surgical excision, , trichloroacetic acid, cryotherapy | 
| 
 | 
Multiple, reddish-yellow papules at extensor surface of extremities & buttocks(Appear suddenly) | 
| 
 | 
Chylomicron and TG (fasting level >1,000 mg/dL, chylomicrons+), 嚴重會pancreatitis | 
| 
 | 
Severe Hypertriglyceridemia(typeI: Familial chylomicronemia; typeV: Mixed hyperlipidemia), obesity, alcohol abuse, diabetes (type 2), and drugs | 
| 
 | 
Lipoprotein lipase deficiency or apoC2 deficiency | 
| 
 | 
Eruptivee xanthoma, Lipemia retinalis (milky plasma which can be visualized in retinal veins)  
很少coronary atherosclerosis. | 
| 
 | 
LDL <50 mg/dL 
↑chylomicrons and VLDL,導致lipoprotein lipase活性很低 | 
| 
 | 
dietary modification. | 
| 
 | 
Retinoids, estrogen, and protease inhibitors. | 
| 
 | 
限 fat and sugars, weight loss,control diabetes, fibrates & fish oil.  | 
| Xanthomas in Children | |
| 
 | 
homozygous FH, phytosterolemia/sitosterolemia, CTX, and Alagille syndrome | 
| 
 | 
an inherited syndrome of biliary hypoplasia | 
| 
 | 
A characteristic facies (a prominent forehead, hypertelorism, pointed chin, and nasal dystrophy), Cirrhosis, | 
| 
 | 
cholesterol | 
| 
 | 
liver transplantation | 
| Verruciform Xanthoma(VX) | |
| 
 | 
oral cavity | 
| 
 | 
foamy histiocytes within elongated dermal papillae | 
| 
 | 
congenital hemidysplasia with ichthyosiform erythroderma and limb defects (CHILD) | 
| 
 | 
Epidermolysis bullosa | 
| 
Laboratory of xanthomas | |
| 
 | 
urine protein, serum creatinine(排除nephrotic syn.) and a hepatic panel(排除肝炎TG↑ & 膽道阻塞: LDL&Alp↑), fasting glucose(排除DM), thyroid function tests(排除hypothyroidism), a fasting lipid profile, lipoprotein(a), apoE genotyping, β-sitosterol, campesterol, and cholestanol. | 
| 
 | 
fasts overnight | 
| 
 | 
gas chromatography | 
| 
 | 
LDL cholesterol (>160 mg/dL) or triglycerides (>150 mg/dL), or decreased levels of HDL cholesterol (<40 mg/dL) | 
| 
 | 
↑TG, ↓HDL | 
| 
 | 
↑LDL | 
| 
 | 
↑TG, ↑HDL | 
| 
Hyperlipidemias的治療 | |
| 
 | 
↑ physical activity /weight control( preventing diabetes, ↓triglycerides, and ↑HDL) 
Dietary management: ↓saturated fat/trans fats, ↓ cholesterol to <200 mg/day, vegetable oils, fish intake. | 
| 
 | 
↓LDL: Statins > ezetimibe>resins.  
↓TG: Fibrates(fenofibrate)> fish oil>niacin therapy.  
↑HDL: Niacin | 
| 
 | |
| 
 | 
dyspepsia, headaches, muscle or joint aches, liver transaminitis,severe myopathy leading to rhabdomyolysis. | 
| 
 | |
| 
 | 
PPAR-αagonists | 
| 
 | 
dyspepsia, gallstones(cholesterol secretion into bile) 
會增強warfarin and certain hypoglycemic作用 | 
| 
 | 
Niaspan: extended release product (less flushing 2 g/day taken at bedtime)  | 
| 
 | |
| 
 | 
liver disease, gastric ulcer. | 
| 
 | 
NPC1L1 inhibitor 
Cholesterol and plant sterols經由 Niemann-Pick C-like protein 1 (NPC1L1) transporter吸收入腸 | 
| 
 | 
對statins無效者 | 
| 
 | 
↓LDL&CRP | 
| 
 | |
| 
 | 
bind bile acids in intestine→↑conversion of liver cholesterol to bile acids/↑LDL receptors in liver→↓LDL | 
| 
 | |
| 
 | 
eicosapentanoic acid (EPA) :消炎↓ immune response(↓IL-1, 6 and TNF-α), ↓ helper T cells & delayed hypersensitivity response  
decohexanoic acid (DHA): 降血脂↓ TG, ↑HDL | 
| 
 | 
↓dementia and Alzheimer disease 
↓CHD, death from MI | 
此外,這幾個表也請注意一下。
Table 135-1 Clinical Presentations of Xanthomas
| 
Type of Xanthoma | 
Genetic Disorders | 
Secondary Disorders | 
| 
Eruptive | 
Familial lipoprotein lipase deficiency | 
Obesity | 
| 
ApoC-II deficiency | 
Cholestasis | |
| 
ApoA-I and apoA-I/C-III deficiency | 
Diabetes | |
| 
Familial hypertriglyceridemia | 
Medications: retinoids, estrogen therapy, protease inhibitors | |
| 
Familial hypertriglyceridemia with chylomicronemia | ||
| 
Tuberous | 
Familial hypercholesterolemia | 
Monoclonal gammopathies | 
| 
Familial dysbetalipoproteinemia | 
Multiple myeloma | |
| 
Phytosterolemia | 
Leukemia | |
| 
Tendinous | 
Familial hypercholesterolemia | |
| 
Familial defective apoB | ||
| 
Familial dysbetalipoproteinemia | ||
| 
Phytosterolemia | ||
| 
Cerebrotendinous xanthomatosis | ||
| 
Planar | ||
| 
Palmar | 
Familial dysbetalipoproteinemia | |
| 
Homozygous apoA-I deficiency | ||
| 
Intertriginous | 
Familial homozygous hypercholesterolemia | 
Cholestasis | 
| 
Diffuse | 
Monoclonal gammopathies, cholestasis | |
| 
Familial hypercholesterolemia | ||
| 
Xanthelasma | 
Familial dysbetalipoproteinemia | 
Monoclonal gammopathies | 
| 
Other | ||
| 
Corneal arcus | 
Familial hypercholesterolemia | |
| 
Tonsillar | 
Tangier disease | 
Table 135-2 Frederickson Classification of Familial Hyperlipidemias (Only Occasionally Used)
| 
Frederickson Classification | 
Condition | 
Defect | 
Lipoprotein Increase | 
Type of Xanthoma | 
| 
Type I | 
Familial chylomicronemia | 
Decreased lipoprotein lipase or altered apoC-II | 
Chylomicrons (and VLDL) | 
Eruptive xanthomata | 
| 
Type IIa | 
Familial hypercholesterolemia 
Heterozygous    
Homozygous    | 
LDL receptor or apoB deficiency | 
LDL | 
Tendon, tuberous, plane xanthomas (xanthelasma and intertriginous) 15% with xanthoma by second decade 
Xanthomata by age 6 years | 
| 
Type IIba | 
Familial combined hypercholesterolemia | 
Decreased LDL receptor and increased apoB | 
LDL and VLDL | 
Usually absent, but can have xanthomas as in type IIa | 
| 
Type III | 
Familial dysbetalipoproteinemia | 
Defective apoE-2 synthesis | 
IDL | 
Palmar, tuberous, tubo-eruptive xanthoma, xanthelasma | 
| 
Type IVb | 
Familial hypertriglyceridemia (pure) | 
Increased VLDL production and decreased elimination | 
VLDL | 
Rare eruptive xanthomas | 
| 
Type V | 
Mixed hyperlipidemia | 
Increased VLDL production and decreased LPL | 
VLDL and chylomicrons | 
Eruptive xanthomas | 
Most familial hyperlipidemias associated with xanthomas are rare.
Box 135-1 Differential Diagnosis of Xanthomas
| 
 | 
 
